EUVIMEDEUVIMED entdecken
Crossref

Patient Factors Influence Minimal Clinically Important Difference for the SNOT‐22 in Medically Treated Chronic Rhinosinusitis

Mohamed A Aboueisha iD, Felix E Fernández-Penny iD, Jacob Hodges, Hector A Perez, Ashton E Lehmann, Ian M Humphreys iD, Waleed M Abuzeid, Aria Jafari iD

International Forum of Allergy & Rhinology · 2025

DOI: 10.1002/alr.23510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2025. Verfasst von Mohamed A Aboueisha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Minimal Clinically Important Difference, Sino-Nasal Outcome Test. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The present study explores the effect of sociodemographics and comorbidities on the calculated minimal clinically important difference (MCID) for 22‐item Sinonasal Outcome Test (SNOT‐22) scores in patients with medically treated chronic rhinosinusitis (CRS). The importance of delineating a threshold to indicate clinically meaningful changes perceived by a patient is well acknowledged, yet the influence of patient‐specific factors on MCID has not been fully elucidated.

Methods

Patients with CRS ( n = 221) presenting to a tertiary care practice reported their change in disease burden with anchor questions following CRS‐directed medical treatment. Baseline sociodemographics, pertinent history, and comorbid conditions, as well as pre‐ and post‐treatment SNOT‐22 scores were also collected. Adjusted logistic regression was utilized to determine the factors influencing MCID.

Results

Among the 221 patients, 43.9% ( n = 97) reported improvement following medical treatment. Gender, education level, depression, and migraine were identified as significant factors influencing perceived improvement. Our predictive model, incorporating these variables, achieved an area under the receiver operating characteristic curve of 0.818 (95% confidence interval [CI] = 0.762, 0.875), with a sensitivity of 74.4% and specificity of 77.9%. Changes in SNOT‐22 scores were not strongly associated with perceived improvement in patients with depression (odds ratio [OR] = 1.06; 95% CI = 0.98, 1.14; p = 0.140). Conversely, patients with migraines perceived more pronounced improvements or deteriorations at the extremes of SNOT‐22 score changes (OR = 0.84; 95% CI = 0.76, 0.93; p = 0.001).

Conclusion

Our findings underscore the substantial impact of patient‐specific sociodemographics and comorbidities on the calculation of MCID values for the SNOT‐22. This study advances our understanding of variability in MCID and demonstrates the complex milieu of factors affecting patients’ perceived clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SinusitisRhinitisMinimal Clinically Important DifferenceSino-Nasal Outcome TestHumansMaleFemaleChronic DiseaseMiddle AgedAdultAgedComorbidityMigraine DisordersDepressionTreatment OutcomeRhinosinusitis

Stichwörter der Autor:innen

CRSMCIDSNOT‐22outcomespatient reportedquality of liferhinosinusitis

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of California, Davis, California, USA.
  • Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Department of Otolaryngology, Geisinger Health System, Danville, Pennsylvania, USA.

ORCID-Profile: Mohamed A Aboueisha, Felix E Fernández-Penny, Ian M Humphreys, Aria Jafari

Zitieren

APA

Aboueisha, M. A., Fernández-Penny, F. E., Hodges, J., Perez, H. A., Lehmann, A. E., Humphreys, I. M., Abuzeid, W. M., & Jafari, A. (2025). Patient Factors Influence Minimal Clinically Important Difference for the SNOT‐22 in Medically Treated Chronic Rhinosinusitis. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23510

Vancouver

Aboueisha MA, Fernández-Penny FE, Hodges J, Perez HA, Lehmann AE, Humphreys IM, et al. Patient Factors Influence Minimal Clinically Important Difference for the SNOT‐22 in Medically Treated Chronic Rhinosinusitis. International Forum of Allergy & Rhinology. 2025. doi:10.1002/alr.23510

BibTeX
@article{Aboueisha2025,
  author = {Aboueisha, Mohamed A and Fernández-Penny, Felix E and Hodges, Jacob and Perez, Hector A and Lehmann, Ashton E and Humphreys, Ian M and Abuzeid, Waleed M and Jafari, Aria},
  title = {Patient Factors Influence Minimal Clinically Important Difference for the SNOT‐22 in Medically Treated Chronic Rhinosinusitis},
  journal = {International Forum of Allergy & Rhinology},
  year = {2025},
  doi = {10.1002/alr.23510}
}
Kostenlos starten →